OLOleg E. Latkin

Oleg E. Latkin

*This is an algorithmically generated author record based on publicly available information.

Oleg E. Latkin has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Role of intravascular ultrasound imaging in minimally enhanced percutaneous coronary interventions in patients with acute coronary syndrome

    by O. E. Zauralov, V. A. Solovyev, V. N. Ardeev, Yu. Yu. Garin, I. M. Ibragimov, K. L. Kozlov, S. S. Mikhailov, I. R. Kirpichnikov, M. A. Belkov, O. E. Latkin, et al.

    Aim. To evaluate the role of intravascular ultrasound (IVUS) in performing percutaneous coronary interventions (PCI) with minimal contrast enhancement in patients with acute coronary syndrome (ACS). Material and methods . The single-center retrospective study included 269 patients with nonST-segment elevation ACS (NSTE-ACS) who underwent coronary artery stenting. Patients were divided into three following groups: group 1 — angiography-guided PCI (n=100), group 2 — PCI with IVUS use (n=100), and group 3 — PCI with the combined use of IVUS and minimal contrast agent administration (n=69). The primary analysis included the assessment of contrast agent volume during PCI, the changes of creatinine level, glomerular filtration rate, and the incidence of acute kidney injury in patients with NSTE-ACS. Results. The smallest contrast agent amount (73,3±5,1 ml) was administered to patients in group 3, where PCI was accompanied by the combined use of IVUS and minimal contrast agent administration (analysis of variance [ANOVA]; pConclusion . Quantitative parameters of average contrast agent administration during PCI in the angiographic and IVUS control groups were identified. Some renal function parameters in these groups were assessed. The effectiveness of the combined use of IVUS and minimal contrast agent administration in patients with NSTE-ACS was shown.


  • Open Access

    Role of intravascular ultrasound imaging in minimally enhanced percutaneous coronary interventions in patients with acute coronary syndrome

    by O. E. Zauralov, V. A. Solovyev, V. N. Ardeev, Yu. Yu. Garin, I. M. Ibragimov, K. L. Kozlov, S. S. Mikhailov, I. R. Kirpichnikov, M. A. Belkov, O. E. Latkin, et al.

    Aim. To evaluate the role of intravascular ultrasound (IVUS) in performing percutaneous coronary interventions (PCI) with minimal contrast enhancement in patients with acute coronary syndrome (ACS).Material and methods. The single-center retrospective study included 269 patients with nonST-segment elevation ACS (NSTE-ACS) who underwent coronary artery stenting. Patients were divided into three following groups: group 1 — angiography-guided PCI (n=100), group 2 — PCI with IVUS use (n=100), and group 3 — PCI with the combined use of IVUS and minimal contrast agent administration (n=69). The primary analysis included the assessment of contrast agent volume during PCI, the changes of creatinine level, glomerular filtration rate, and the incidence of acute kidney injury in patients with NSTE-ACS.Results. The smallest contrast agent amount (73,3±5,1 ml) was administered to patients in group 3, where PCI was accompanied by the combined use of IVUS and minimal contrast agent administration (analysis of variance [ANOVA]; pConclusion. Quantitative parameters of average contrast agent administration during PCI in the angiographic and IVUS control groups were identified. Some renal function parameters in these groups were assessed. The effectiveness of the combined use of IVUS and minimal contrast agent administration in patients with NSTE-ACS was shown.

  • Open Access

    Antegrade endobiliary forceps biopsy under the optical coherence tomography control in the diagnosis of Klatskin tumor: preliminary results

    by Aleхey V. Kozlov, Aleksey A. Polikarpov, Andrey V. Moiseenko, Pavel G. Tarazov, Alexander I. Urbanskiy, Oleg E. Latkin, Dmitrii A. Granov

    Background: Transcutaneous transhepatic endobiliary forceps biopsy is an accepted method for verification of extrahepatic cholangiocarcinoma, but its sensitivity ranges from zero to 94%. In the recent years, optical coherence tomography (OCT) has been actively used to diagnose malignancies. Aim: To assess diagnostic accuracy of the OCT-assisted intraductal forceps biopsy in patients with Klatskin tumor. Materials and methods: From 2013 to 2021, 161 patients with preliminary diagnosis of Klatskin tumor were seen in Russian Scientific Center of Radiology and Surgical Technologies named after Academician A.M. Granov. The retrospective study included 48 patients and 51 procedures of the forceps biopsy. In 14 (29%) patients of the main study group, the biopsy procedure was performed with OCT assistance, whereas the control group (34 patients, 71%) had their biopsies without the OCT. Results: All procedures were technically successful. In the main and in the control study groups, sensitivity was 92.3% versus 73.3% (p = 0.32) and specificity 100% versus 85.7% (p = 0.88), respectively. Malignant neoplasm of the biliary tract was found in 13 cases versus 23 in the control group, with the degree of the tumor differentiation being determined in 64.3% (n = 9), versus 48.7% (n = 18) (p = 0.89), respectively. There were no adverse events associated with OCT and biopsy sampling in the main study group. In the control group, 4/37 procedures (10.8%) were associated with hemobilia, which was successfully treated conservatively within 24 hours without any prolongation of the hospital stay. Conclusion: Our preliminary results indicate that antegrade endobiliary forceps biopsy is a safe and informative technique. The OCT navigation increases the sensitivity and specificity of the diagnosis. This allows for a personalized choice of chemotherapy. OCT is a promising technique for differential diagnosis of Klatskin tumor from benign biliary strictures. Further large-scale studies are required to introduce it into everyday practice.


  • Open Access

    May Measurement Month 2019: adherence to treatment and hypertension control in Russia

    by О. П. Ротарь, K. M. Tolkunova, V. N. Solntsev, A. M. Erina, M. A. Boyarinova, A. S. Alieva, E. V. Moguchaya, E. P. Kolesova, E. I. Pavlyuk, O. M. Posnenkova, et al.

    The International Society of Hypertension and the World Hypertension League initiated a blood pressure screening study called May Measurement Month 2019 (MMM19) to improve the detection of elevated blood pressure (BP) and to assess BP control in patients with hypertension (HTN).Aim. To assess adherence to treatment of the hypertensive population according to MMM19 campaign in Russia.Material and methods. During May 2019, 5394 people from 21 regions of Russia took part in the screening. Participation was voluntary and did not imply gender restrictions; all subjects were over 18 years of age. During the screening, BP was measured three times using electronic and mechanical sphygmomanometers, as well as a questionnaire on the diabetes, history of cardiovascular events, smoking, and alcohol consumption was filled. Information was also collected on the date of last BP check and the administration of statins, acetylsalicylic acid and antihypertensive drugs. Data on height and body weight was obtained from respondents.Results. The analysis included data from 5274 participants aged 18 to 96 years (men — 1834 (34,8%)). Median age was 25 years, quartiles — 20 and 49 years. According to MMM19 data, the proportion of HTN patients in the Russian population was 31,9%, and with the exception of participants under 25 years old — 51,5%. Patients with HTN over 25 years old take antihypertensive therapy in 73,6%; 38,6% are characterized by irregular drug intake. Only 11,8% of men and 17,2% of women reach the target blood pressure Conclusion. According to MMM19 in Russia, only a third of high-risk patients measured BP over the past 12 months. There is also low adherence to antihypertensive therapy and inadequate control of HTN. Patients with HTN and a history of cardiovascular events are more likely to take antihypertensives regularly.